Inspire Investing LLC Purchases 5,753 Shares of Acadia Healthcare Company, Inc. $ACHC

Inspire Investing LLC increased its position in shares of Acadia Healthcare Company, Inc. (NASDAQ:ACHC) by 51.5% in the 2nd quarter, HoldingsChannel reports. The firm owned 16,927 shares of the company’s stock after acquiring an additional 5,753 shares during the quarter. Inspire Investing LLC’s holdings in Acadia Healthcare were worth $384,000 at the end of the most recent reporting period.

Several other institutional investors have also recently bought and sold shares of the business. Hawk Ridge Capital Management LP raised its stake in Acadia Healthcare by 437.5% during the first quarter. Hawk Ridge Capital Management LP now owns 2,473,226 shares of the company’s stock worth $74,988,000 after acquiring an additional 2,013,126 shares in the last quarter. Citigroup Inc. raised its stake in Acadia Healthcare by 5,144.2% during the first quarter. Citigroup Inc. now owns 2,376,209 shares of the company’s stock worth $72,047,000 after acquiring an additional 2,330,898 shares in the last quarter. Maverick Capital Ltd. raised its stake in Acadia Healthcare by 116.3% during the first quarter. Maverick Capital Ltd. now owns 2,246,923 shares of the company’s stock worth $68,127,000 after acquiring an additional 1,208,296 shares in the last quarter. Abrams Bison Investments LLC acquired a new position in Acadia Healthcare during the first quarter worth about $55,182,000. Finally, Khrom Capital Management LLC raised its stake in Acadia Healthcare by 26.9% during the first quarter. Khrom Capital Management LLC now owns 1,587,299 shares of the company’s stock worth $48,127,000 after acquiring an additional 336,297 shares in the last quarter.

Wall Street Analyst Weigh In

Several research analysts have commented on ACHC shares. Guggenheim lowered their target price on Acadia Healthcare from $36.00 to $29.00 and set a “buy” rating for the company in a research note on Thursday, August 7th. Mizuho lowered their price objective on Acadia Healthcare from $32.00 to $22.00 and set a “neutral” rating for the company in a research note on Wednesday, August 13th. KeyCorp lowered their price objective on Acadia Healthcare from $55.00 to $35.00 and set an “overweight” rating for the company in a research note on Wednesday, October 8th. UBS Group lowered their price objective on Acadia Healthcare from $45.00 to $31.00 and set a “buy” rating for the company in a research note on Thursday, August 7th. Finally, Royal Bank Of Canada lowered their price objective on Acadia Healthcare from $43.00 to $28.00 and set an “outperform” rating for the company in a research note on Wednesday, August 13th. Eight research analysts have rated the stock with a Buy rating, five have issued a Hold rating and one has assigned a Sell rating to the company. According to data from MarketBeat, the company has an average rating of “Moderate Buy” and a consensus target price of $35.09.

Acadia Healthcare Stock Performance

NASDAQ:ACHC opened at $24.74 on Friday. The company has a market capitalization of $2.28 billion, a PE ratio of 16.38, a P/E/G ratio of 4.89 and a beta of 0.90. The company has a 50 day simple moving average of $23.01 and a two-hundred day simple moving average of $23.27. The company has a debt-to-equity ratio of 0.73, a quick ratio of 1.32 and a current ratio of 1.32. Acadia Healthcare Company, Inc. has a fifty-two week low of $17.13 and a fifty-two week high of $60.52.

Acadia Healthcare (NASDAQ:ACHC) last released its earnings results on Tuesday, August 5th. The company reported $0.83 earnings per share for the quarter, beating analysts’ consensus estimates of $0.71 by $0.12. The business had revenue of $869.23 million during the quarter, compared to the consensus estimate of $839.59 million. Acadia Healthcare had a net margin of 4.31% and a return on equity of 8.34%. The company’s revenue for the quarter was up 9.2% compared to the same quarter last year. During the same quarter in the prior year, the firm posted $0.91 EPS. Acadia Healthcare has set its FY 2025 guidance at 2.450-2.65 EPS. Research analysts anticipate that Acadia Healthcare Company, Inc. will post 3.38 earnings per share for the current year.

Acadia Healthcare Profile

Acadia Healthcare Company, Inc provides behavioral healthcare services in the United States and Puerto Rico. The company develops and operates acute inpatient psychiatric facilities, specialty treatment facilities comprising residential recovery facilities and eating disorder facilities, comprehensive treatment centers, and residential treatment centers, as well as facilities offering outpatient behavioral healthcare services for the behavioral healthcare and recovery needs of communities.